Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,666 | 45,264 | 5,377 | 23 | N/A |
| Receivables | 0 | N/A | 4 | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 10 | 0 |
| TOTAL | $27,896 | $46,034 | $5,472 | $32 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 74 | 29 | 49 | N/A | N/A |
| Other Non-Current Assets | 24 | 45 | 45 | 0 | 0 |
| TOTAL | $98 | $74 | $94 | $N/A | $N/A |
| Total Assets | $27,994 | $46,108 | $5,566 | $32 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 306 | 1,027 | 87 | 7 | 0 |
| Accrued Expenses | 1,327 | 257 | 108 | N/A | N/A |
| TOTAL | $1,634 | $1,284 | $213 | $8 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 37 | 0 | 0 |
| TOTAL | $N/A | $N/A | $37 | $N/A | $N/A |
| Total Liabilities | $1,634 | $1,284 | $250 | $8 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 755 | 751 | 206 | N/A | N/A |
| Common Shares | 1 | 1 | 0 | 0 | N/A |
| Retained earnings | -68,237 | -47,864 | -37,274 | -5 | N/A |
| Other shareholders' equity | -41 | 0 | 0 | 0 | 0 |
| TOTAL | $26,360 | $44,824 | $5,316 | $25 | $N/A |
| Total Liabilities And Equity | $27,994 | $46,108 | $5,566 | $32 | $0 |